Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Latest News about Unassigned
 
< Previous 1 2 Next >
19 Foreign Stocks With Cheap Valuation And Good Yields
May 15, 2013
about ABX , GOLD , GSK , and 2 more.
category Unassigned , Gold & Silver
from Trefis
Bristol-Myers Squibb’s New Drugs Can Help Reverse Its Sinking Revenue
April 26, 2013
about ABT , BMY , GSK
category Pharmaceuticals , Unassigned
from Trefis
Brystol-Myers Squibbs Preview: Performance Of New Drugs The Key
April 24, 2013
about ABT , BMY , GSK , and 1 more.
category Pharmaceuticals , Unassigned
from Trefis
Boston Scientific: A Look At The Peripheral Intervention Business
April 16, 2013
about BSX , GSK , JNJ , and 2 more.
category Pharmaceuticals , Unassigned , Medical Devices & Supplies
from Trefis
Roche Earnings Preview: What We Are Watching
April 08, 2013
about GSK , NVS , PFE , and 1 more.
category Pharmaceuticals , Unassigned
from Trefis
100 Guru Stock Buy List | The Most Bought Stocks
April 03, 2013
about DD , GSK , INTC , and 1 more.
category Semiconductor , Unassigned , Chemicals
from Trefis
Warren Buffett’s Best Yielding Dividend Stocks
March 19, 2013
about COP , D , GCI , and 2 more.
category Unassigned , Oil & Gas
from Trefis
Baidu Is Cheap But Faces Headwinds From Slowing Search Advertising Growth In China
March 18, 2013
about BIDU , GOOG , QIHU , and 1 more.
category Unassigned , Internet
from Trefis
10 Best Dividend Paying Drug Manufacturing Stocks
March 05, 2013
about ABT , BMY , GSK , and 4 more.
category Pharmaceuticals , Unassigned
from Trefis
Here’s What Matters For Baidu’s $115 Valuation
March 01, 2013
about BIDU , GOOG , QIHU , and 1 more.
category Unassigned , Internet
from Trefis
Heinz Savors Emerging Markets Growth And Reaffirms Brand Strength
February 22, 2013
about FOOD , HNZ , HSH , and 2 more.
category Food & Beverage , Unassigned , Retail & Household Products
from Trefis
Pozen: An Undervalued Investment And Catalyst Trade Opportunity
February 11, 2013
about AZN , GSK , JNJ , and 1 more.
category Pharmaceuticals , Unassigned
from Trefis
Bristol-Myers’ Sales Fall On Plavix Patent Cliff But Outlook Is Stable
January 28, 2013
about AZN , BMY , GSK , and 3 more.
category Pharmaceuticals , Unassigned
from Trefis
Plavix Patent Cliff Will Impact Bristol-Myers’ Earnings
January 23, 2013
about AZN , BMY , GSK , and 3 more.
category Pharmaceuticals , Unassigned
from Trefis
The 3 Best Yielding Top Stocks From Ken Fisher’s Q3/2012 Fund Portfolio
December 28, 2012
about GE , GSK , INDUSTRIALS , and 1 more.
category Pharmaceuticals , Industrials , Unassigned
from Trefis
Zacks Analyst Jason Napodano’s Seven Biotech Picks Will Keep Your Profits on Solid Ground
December 13, 2012
about DEPO , GSK , JNJ , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Warren Buffett’s Best Yielding Dividend Stocks
December 05, 2012
about COP , GCI , GSK , and 1 more.
category Unassigned , Oil & Gas
from Trefis
Friday’s Small Cap BioPharma Catalyst Trade And Speculation Investment List
November 30, 2012
about ACAD , ALXA , ARNA , and 3 more.
category Pharmaceuticals , Unassigned
from Trefis
Applying the Venture Capital Model to Public Companies: Hugh Cleland
November 28, 2012
about CTRX , GSK , LLY , and 3 more.
category Pharmaceuticals , Unassigned
from Trefis
Bristol-Myers’ Eliquis To Exploit The NVAF Market Post Approval In The EU
November 26, 2012
about AZN , BMY , GSK , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Wednesday’s Bio-Pharma Catalyst Trades And Watch List
November 21, 2012
about AVEO , DNDN , EXEL , and 4 more.
category Pharmaceuticals , Unassigned
from Trefis
Bristol-Myers Bolsters Portfolio With EU Approval For New Kind Of Diabetes Drug
November 19, 2012
about AZN , BMY , GSK , and 3 more.
category Pharmaceuticals , Unassigned
from Trefis
Is There Big Value In Addiction Fighting Pharmas?
November 15, 2012
about ABT , CPRX , GSK , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Upcoming BioPharma Catalyst Trades to Consider
November 13, 2012
about AMRN , GSK , HZNP , and 3 more.
category Pharmaceuticals , Unassigned
from Trefis
Boston Scientific Acquires Vessix Vascular To Bolster Peripheral Intervention Business
November 09, 2012
about BSX , GSK , JNJ , and 2 more.
category Pharmaceuticals , Unassigned , Medical Devices & Supplies
from Trefis
The 5 Best Stocks With Dividend Growth From Last Week (Oct 29 – Nov 04, 2012)
November 06, 2012
about EL , FOOD , GSK , and 3 more.
category Food & Beverage , Unassigned , Beauty & Personal Care
from Trefis
Why Teva Pharmaceutical Is An Attractive Buying Opportunity
November 06, 2012
about ABT , GSK , PFE , and 1 more.
category Pharmaceuticals , Unassigned
from Trefis
Emerging Market Health Care: Prognosis Profitable
October 11, 2012
about GSK , MRK , NVS , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Pfizer’s $26 Value Finds Support With Strong Prevnar Vaccine Outlook
October 09, 2012
about ABT , GSK , MRK , and 1 more.
category Pharmaceuticals , Unassigned
from Trefis
Boston Scientific Acquires BridgePoint Medical To Bolster Interventional Cardiology Business
September 21, 2012
about BSX , GSK , JNJ , and 2 more.
category Pharmaceuticals , Unassigned , Medical Devices & Supplies
from Trefis
< Previous 1 2 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
2
The Future of Android Looks More Like Apple Inc.
Mike Schuster
3
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer
4
Tech News: Tesla Motors Inc's First Recall Is a Display of Public Relations Prowess
Josh Wolonick
5
The Waning Integrity of US Financial Markets
Todd Harrison